BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34996328)

  • 21. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
    Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
    Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.
    Jayaprakasan K; Campbell B; Hopkisson J; Johnson I; Raine-Fenning N
    Fertil Steril; 2010 Feb; 93(3):855-64. PubMed ID: 19046583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing four ovarian reserve markers--associations with ovarian response and live births after assisted reproduction.
    Brodin T; Hadziosmanovic N; Berglund L; Olovsson M; Holte J
    Acta Obstet Gynecol Scand; 2015 Oct; 94(10):1056-63. PubMed ID: 26184379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do we overlook predictive factors in Poseidon 1 patients? A retrospective analysis co-evaluating antral follicle counts & diameters.
    Uncu G; Aslan K; Cakir C; Avci B; Kasapoglu I; Alviggi C
    J Ovarian Res; 2024 Jan; 17(1):1. PubMed ID: 38169411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study.
    Drakopoulos P; van de Vijver A; Schutyser V; Milatovic S; Anckaert E; Schiettecatte J; Blockeel C; Camus M; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Jan; 32(1):208-214. PubMed ID: 27927849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction value of anti-Mullerian hormone (AMH) serum levels and antral follicle count (AFC) in hormonal contraceptive (HC) users and non-HC users undergoing IVF-PGD treatment.
    Bas-Lando M; Rabinowitz R; Farkash R; Algur N; Rubinstein E; Schonberger O; Eldar-Geva T
    Gynecol Endocrinol; 2017 Oct; 33(10):797-800. PubMed ID: 28454495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The comparison of evaluative effectiveness between antral follicle count/age ratio and ovarian response prediction index for the ovarian reserve and response functions in infertile women.
    Zhou SJ; Zhao MJ; Li C; Su X
    Medicine (Baltimore); 2020 Sep; 99(36):e21979. PubMed ID: 32899038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The physiology and clinical utility of anti-Mullerian hormone in women.
    Dewailly D; Andersen CY; Balen A; Broekmans F; Dilaver N; Fanchin R; Griesinger G; Kelsey TW; La Marca A; Lambalk C; Mason H; Nelson SM; Visser JA; Wallace WH; Anderson RA
    Hum Reprod Update; 2014; 20(3):370-85. PubMed ID: 24430863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response.
    Iliodromiti S; Anderson RA; Nelson SM
    Hum Reprod Update; 2015; 21(6):698-710. PubMed ID: 25489055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilisation who had discordant anti-Mullerian hormone and antral follicle count measurements: a retrospective study.
    Li HW; Lee VC; Lau EY; Yeung WS; Ho PC; Ng EH
    PLoS One; 2014; 9(10):e108493. PubMed ID: 25313856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF.
    Fabregues F; González-Foruria I; Peñarrubia J; Carmona F
    Hum Reprod; 2018 Sep; 33(9):1696-1704. PubMed ID: 30016431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of anti-Mullerian hormone in predicting the response to clomiphene citrate in unexplained infertility.
    Coskun B; Dilbaz B; Karadag B; Coskun B; Tohma YA; Dur R; Akkurt MO
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):713-717. PubMed ID: 30342657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome.
    Keane K; Cruzat VF; Wagle S; Chaudhary N; Newsholme P; Yovich J
    Reprod Biol; 2017 Mar; 17(1):51-59. PubMed ID: 28132758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antral follicle count (AFC) and serum anti-Müllerian hormone (AMH) are the predictors of natural fecundability have similar trends irrespective of fertility status and menstrual characteristics among fertile and infertile women below the age of 40 years.
    Khan HL; Bhatti S; Suhail S; Gul R; Awais A; Hamayun H; Enver F; Abbas S; Hassan Z; Nisar R; Sardar S; Asif W
    Reprod Biol Endocrinol; 2019 Feb; 17(1):20. PubMed ID: 30744650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Female adolescents and young women previously treated for pediatric malignancies: assessment of ovarian reserve and gonadotoxicity risk stratification for early identification of patients at increased infertility risk.
    Parissone F; Di Paola R; Balter R; Garzon S; Zaffagnini S; Neri M; Vitale V; Tridello G; Cesaro S
    J Pediatr Endocrinol Metab; 2021 Jan; 34(1):25-33. PubMed ID: 33068384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of baseline antral follicle count and anti-Mullerian hormone in the index stimulation cycle of IVF treatment in predicting outcome of subsequent frozen-thawed embryo transfers.
    Li HW; Lee VC; Lau EY; Yeung WS; Ho PC; Ng EH
    Gynecol Endocrinol; 2014 Jul; 30(7):490-3. PubMed ID: 24641676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter evaluation of the Access AMH antimüllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation.
    Baker VL; Gracia C; Glassner MJ; Schnell VL; Doody K; Coddington CC; Shin SS; Marshall LA; Alper MM; Morales AJ; Pavone ME; Behera MA; Zbella EA; Shapiro BS; Straseski JA; Broyles DL
    Fertil Steril; 2018 Aug; 110(3):506-513.e3. PubMed ID: 29960708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of antral follicle count and anti-Müllerian hormone for follicle and oocyte developmental competence during the early prepubertal period in a sheep model.
    Torres-Rovira L; Gonzalez-Bulnes A; Succu S; Spezzigu A; Manca ME; Leoni GG; Sanna M; Pirino S; Gallus M; Naitana S; Berlinguer F
    Reprod Fertil Dev; 2014 Oct; 26(8):1094-106. PubMed ID: 24008140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of serum anti-Mullerian hormone (AMH) levels and antral follicle count (AFC) to predict the number of oocytes collected and availability of embryos for cryopreservation in IVF.
    Kotanidis L; Nikolettos K; Petousis S; Asimakopoulos B; Chatzimitrou E; Kolios G; Nikolettos N
    J Endocrinol Invest; 2016 Dec; 39(12):1459-1464. PubMed ID: 27465668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicentre evaluation of the Elecsys
    Jacobs MH; Reuter LM; Baker VL; Craig LB; Sakkas D; Surrey E; Doody KJ; Jungheim ES; Bayrak AB; Hund M; Verhagen-Kamerbeek WDJ; Pardue D; Buck K; Timm B
    Reprod Biomed Online; 2019 May; 38(5):845-852. PubMed ID: 30930183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.